August 3, 2026 · Form 4 insider transaction
Carson Michael J. bought 30,000 shares of Nuvectis Pharma, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
The 30,000 shares of restricted common stock will fully vest on August 3, 2027, subject to Mr. Carson's continued service on such date.; Includes shares of restricted common stock.